- Home
- CMRX vs GEVO Comparison
CMRX vs GEVO Comparison
Compare CMRX & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRX
- GEVO
- Stock Information
- Founded
- CMRX 2000
- GEVO 2005
- Country
- CMRX United States
- GEVO United States
- Employees
- CMRX N/A
- GEVO N/A
- Industry
- CMRX Biotechnology: Pharmaceutical Preparations
- GEVO Major Chemicals
- Sector
- CMRX Health Care
- GEVO Industrials
- Exchange
- CMRX Nasdaq
- GEVO Nasdaq
- Market Cap
- CMRX 394.1M
- GEVO 330.4M
- IPO Year
- CMRX 2013
- GEVO 2011
- Fundamental
- Price
- CMRX $8.51
- GEVO $1.16
- Analyst Decision
- CMRX Hold
- GEVO Buy
- Analyst Count
- CMRX 4
- GEVO 2
- Target Price
- CMRX $8.51
- GEVO $8.63
- AVG Volume (30 Days)
- CMRX 8.5M
- GEVO 3.1M
- Earning Date
- CMRX 03-21-2025
- GEVO 03-27-2025
- Dividend Yield
- CMRX N/A
- GEVO N/A
- EPS Growth
- CMRX N/A
- GEVO N/A
- EPS
- CMRX N/A
- GEVO N/A
- Revenue
- CMRX $212,000.00
- GEVO $16,915,000.00
- Revenue This Year
- CMRX $2,685.38
- GEVO N/A
- Revenue Next Year
- CMRX $1,050.23
- GEVO $917.63
- P/E Ratio
- CMRX N/A
- GEVO N/A
- Revenue Growth
- CMRX N/A
- GEVO N/A
- 52 Week Low
- CMRX $0.75
- GEVO $0.48
- 52 Week High
- CMRX $8.53
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- CMRX 83.55
- GEVO 34.81
- Support Level
- CMRX $8.41
- GEVO $1.25
- Resistance Level
- CMRX $8.52
- GEVO $1.34
- Average True Range (ATR)
- CMRX 0.02
- GEVO 0.09
- MACD
- CMRX -0.14
- GEVO 0.00
- Stochastic Oscillator
- CMRX 72.22
- GEVO 16.25
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.